|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Daniel Tillett
|
3.0K |
1.1M |
6 |
21:44 |
| 21:44 |
ASX - By Stock
|
3.0K
|
1.1M
|
6
|
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Daniel Tillett
|
32K |
11M |
19 |
21:42 |
| 21:42 |
ASX - By Stock
|
32K
|
11M
|
19
|
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Daniel Tillett
|
3.5K |
1.2M |
17 |
21:38 |
| 21:38 |
ASX - By Stock
|
3.5K
|
1.2M
|
17
|
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Daniel Tillett
|
3.0K |
1.1M |
26 |
16:47 |
| 16:47 |
ASX - By Stock
|
3.0K
|
1.1M
|
26
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
Daniel Tillett
|
95 |
43K |
32 |
16/03/26 |
| 16/03/26 |
ASX - By Stock
|
95
|
43K
|
32
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura HARNESS-1 Trial Receives Governance Approval
|
|
Daniel Tillett
|
58 |
15K |
47 |
16/03/26 |
| 16/03/26 |
ASX - By Stock
|
58
|
15K
|
47
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura HARNESS-1 Trial Receives Governance Approval
|
|
Daniel Tillett
|
58 |
15K |
48 |
16/03/26 |
| 16/03/26 |
ASX - By Stock
|
58
|
15K
|
48
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura HARNESS-1 Trial Receives Governance Approval
|
|
Daniel Tillett
|
58 |
15K |
116 |
16/03/26 |
| 16/03/26 |
ASX - By Stock
|
58
|
15K
|
116
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura HARNESS-1 Trial Receives Governance Approval
|
|
Daniel Tillett
|
58 |
15K |
54 |
16/03/26 |
| 16/03/26 |
ASX - By Stock
|
58
|
15K
|
54
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura HARNESS-1 Trial Receives Governance Approval
|
|
Daniel Tillett
|
58 |
15K |
90 |
16/03/26 |
| 16/03/26 |
ASX - By Stock
|
58
|
15K
|
90
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
Daniel Tillett
|
378 |
103K |
35 |
15/03/26 |
| 15/03/26 |
ASX - By Stock
|
378
|
103K
|
35
|
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Daniel Tillett
|
3.5K |
1.2M |
63 |
15/03/26 |
| 15/03/26 |
ASX - By Stock
|
3.5K
|
1.2M
|
63
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura Investor Briefing Hong Kong and Singapore
|
|
Daniel Tillett
|
73 |
19K |
30 |
15/03/26 |
| 15/03/26 |
ASX - By Stock
|
73
|
19K
|
30
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Daniel Tillett
|
28 |
5.6K |
5 |
15/03/26 |
| 15/03/26 |
ASX - By Stock
|
28
|
5.6K
|
5
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Dosed Safely in RC220 Phase 1 Trial
|
|
Daniel Tillett
|
253 |
90K |
5 |
15/03/26 |
| 15/03/26 |
ASX - By Stock
|
253
|
90K
|
5
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura Develops Novel Cardioprotection Blood Test
|
|
Daniel Tillett
|
385 |
75K |
18 |
15/03/26 |
| 15/03/26 |
ASX - By Stock
|
385
|
75K
|
18
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura Develops Novel Cardioprotection Blood Test
|
|
Daniel Tillett
|
385 |
75K |
12 |
15/03/26 |
| 15/03/26 |
ASX - By Stock
|
385
|
75K
|
12
|
|
|
ASX - By Stock
|
RAC |
Re:
Harness 1 Trial, NSCLC
|
|
Daniel Tillett
|
15 |
3.8K |
20 |
15/03/26 |
| 15/03/26 |
ASX - By Stock
|
15
|
3.8K
|
20
|
|
|
ASX - By Stock
|
RAC |
Re:
Harness 1 Trial, NSCLC
|
|
Daniel Tillett
|
15 |
3.8K |
15 |
15/03/26 |
| 15/03/26 |
ASX - By Stock
|
15
|
3.8K
|
15
|
|
|
ASX - By Stock
|
RAC |
Re:
Harness 1 Trial, NSCLC
|
|
Daniel Tillett
|
15 |
3.8K |
13 |
15/03/26 |
| 15/03/26 |
ASX - By Stock
|
15
|
3.8K
|
13
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Dosed Safely in RC220 Phase 1 Trial
|
|
Daniel Tillett
|
253 |
90K |
52 |
13/03/26 |
| 13/03/26 |
ASX - By Stock
|
253
|
90K
|
52
|
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Daniel Tillett
|
3.5K |
1.2M |
37 |
13/03/26 |
| 13/03/26 |
ASX - By Stock
|
3.5K
|
1.2M
|
37
|
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Daniel Tillett
|
3.5K |
1.2M |
10 |
13/03/26 |
| 13/03/26 |
ASX - By Stock
|
3.5K
|
1.2M
|
10
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Daniel Tillett
|
28 |
5.6K |
8 |
13/03/26 |
| 13/03/26 |
ASX - By Stock
|
28
|
5.6K
|
8
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Daniel Tillett
|
28 |
5.6K |
4 |
13/03/26 |
| 13/03/26 |
ASX - By Stock
|
28
|
5.6K
|
4
|
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Daniel Tillett
|
3.5K |
1.2M |
15 |
13/03/26 |
| 13/03/26 |
ASX - By Stock
|
3.5K
|
1.2M
|
15
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Daniel Tillett
|
28 |
5.6K |
51 |
13/03/26 |
| 13/03/26 |
ASX - By Stock
|
28
|
5.6K
|
51
|
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Daniel Tillett
|
32K |
11M |
21 |
13/03/26 |
| 13/03/26 |
ASX - By Stock
|
32K
|
11M
|
21
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Dosed Safely in RC220 Phase 1 Trial
|
|
Daniel Tillett
|
253 |
90K |
83 |
13/03/26 |
| 13/03/26 |
ASX - By Stock
|
253
|
90K
|
83
|
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Daniel Tillett
|
32K |
11M |
20 |
12/03/26 |
| 12/03/26 |
ASX - By Stock
|
32K
|
11M
|
20
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Daniel Tillett
|
28 |
5.6K |
47 |
12/03/26 |
| 12/03/26 |
ASX - By Stock
|
28
|
5.6K
|
47
|
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Daniel Tillett
|
3.0K |
1.1M |
39 |
11/03/26 |
| 11/03/26 |
ASX - By Stock
|
3.0K
|
1.1M
|
39
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Daniel Tillett
|
16K |
5.9M |
33 |
11/03/26 |
| 11/03/26 |
General
|
16K
|
5.9M
|
33
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Daniel Tillett
|
16K |
5.9M |
76 |
11/03/26 |
| 11/03/26 |
General
|
16K
|
5.9M
|
76
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Daniel Tillett
|
16K |
5.9M |
35 |
11/03/26 |
| 11/03/26 |
General
|
16K
|
5.9M
|
35
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Daniel Tillett
|
16K |
5.9M |
37 |
11/03/26 |
| 11/03/26 |
General
|
16K
|
5.9M
|
37
|
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Daniel Tillett
|
32K |
11M |
44 |
11/03/26 |
| 11/03/26 |
ASX - By Stock
|
32K
|
11M
|
44
|
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Daniel Tillett
|
32K |
11M |
169 |
11/03/26 |
| 11/03/26 |
ASX - By Stock
|
32K
|
11M
|
169
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Daniel Tillett
|
16K |
5.9M |
44 |
10/03/26 |
| 10/03/26 |
General
|
16K
|
5.9M
|
44
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Daniel Tillett
|
16K |
5.9M |
21 |
10/03/26 |
| 10/03/26 |
General
|
16K
|
5.9M
|
21
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Daniel Tillett
|
16K |
5.9M |
33 |
10/03/26 |
| 10/03/26 |
General
|
16K
|
5.9M
|
33
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Daniel Tillett
|
16K |
5.9M |
36 |
10/03/26 |
| 10/03/26 |
General
|
16K
|
5.9M
|
36
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Daniel Tillett
|
16K |
5.9M |
35 |
09/03/26 |
| 09/03/26 |
General
|
16K
|
5.9M
|
35
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Daniel Tillett
|
78 |
32K |
8 |
09/03/26 |
| 09/03/26 |
ASX - By Stock
|
78
|
32K
|
8
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Daniel Tillett
|
16K |
5.9M |
81 |
09/03/26 |
| 09/03/26 |
General
|
16K
|
5.9M
|
81
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Daniel Tillett
|
16K |
5.9M |
36 |
09/03/26 |
| 09/03/26 |
General
|
16K
|
5.9M
|
36
|
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Daniel Tillett
|
3.5K |
1.2M |
26 |
06/03/26 |
| 06/03/26 |
ASX - By Stock
|
3.5K
|
1.2M
|
26
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura Oncology Research Symposium Sydney
|
|
Daniel Tillett
|
26 |
8.2K |
47 |
06/03/26 |
| 06/03/26 |
ASX - By Stock
|
26
|
8.2K
|
47
|
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Daniel Tillett
|
3.5K |
1.2M |
20 |
06/03/26 |
| 06/03/26 |
ASX - By Stock
|
3.5K
|
1.2M
|
20
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Daniel Tillett
|
16K |
5.9M |
44 |
06/03/26 |
| 06/03/26 |
General
|
16K
|
5.9M
|
44
|
|